healthcarenewsblogs

  The global apheresis market is presumed to register 10.2 % CAGR during the forecast period (2017-2023), owing to the increasing prevalence of chronic renal diseases, asserts Market Research Future (MRFR). Apheresis is referred to as the procedure of separating and purifying the blood for treating several renal, neurological, autoimmune, hematological, and other diseases. Apheresis involves removal of the blood from the donor or patients and collecting it into an apparatus which separates the component from the blood. The rest of the blood is sent to the patients or the donors. The separation is mainly done using filtration and centrifugation. Competitive Dashboard The major players operating the global market are Kaneka Corporation (Japan), Terumo BCT Inc. (US), Fresenius Medical Care (Germany), Nikkiso Co. Ltd. (Japan), Asahi Kasei Medical Co. Ltd. (Japan), B. Braun Melsungen AG (Germany), Nikkiso Ltd. (Japan), HemaCare Corporation (US), Cerus Corporation (US), Haemonetics Co

  Market Research Future (MRFR) has published a research report that prognosticates vigorous surge for the global renal dialysis market with 7.1% CAGR between 2017 and 2023. In terms of cash, the market is expected to rise with the US $ 26.6 bn by the end of the forecast period. Analyzing the market structure, this report evaluates the future growth potential and observes the strategies of the key players in this market. It also tracks the competitive developments such as joint ventures, mergers, and acquisitions, new product developments, new product developments (R & D) in the market. The factors driving the growth of this market include continuously increasing the prevalence of the kidney and other associated renal diseases, increasing diabetic patients, and patients suffering from hypertension. However, the high cost of treatment and complication after the treatment are likely to slow down the growth of the market. People suffering from kidney failure need renal dialysis whi

  Global Artificial Disc Replacement Market is expected to grow at a CAGR of 15% during forecasted period.On regional basis, global artificial disc replacement market is segmented into North America, Europe, Asia Pacific and Middle East and Africa. North America has a leading market for artificial disc replacement. Due to increasing aging population, increasing healthcare expenditure and higher success rate of artificial disc replacements has boosted the artificial disc replacements market in North America. Europe has the second largest market for artificial disc replacements. Germany, UK and franc are the major contributor of the market. Favorable reimbursement policy structure, well-developed healthcare infrastructure and increasing healthcare expenditure are the driving factor for the market growth. While Asia Pacific is the fastest growing region for the growth of the market. A huge population base and rapid development in Asia Pacific region has provided fuel for the growth of th

  The Global Diphtheria Tetanus and Pertussis Vaccine (DPT) vaccine Market is growing exponentially owing to rising prevalence of chronic disease and increasing usage of combination vaccine and therapy are the major factor driving the DPT vaccine Market . Globally the market for DPT vaccine market is expected to grow at the rate of about 7.3% CAGR from 2016 to 2027. There is an increase in demand of diphtheria tetanus and pertussis vaccine across the globe and rising awareness regarding prevention of diphtheria, tetanus, and pertussis is major factors which are responsible for the growth of this market. The market is expected to show large opportunities in the coming future with the advancement of technology in developing countries and new products with increased accuracy. Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/1357 Global DPT vaccine Market - Company Analysis Merck: Merck provides a wide range of vaccines which includes BCG USP, Pneu

  Neuromodulation is a technology that acts directly upon the nerves, thereby, causing alterations in the nerve activity. This is achieved by delivering electrical or pharmaceutical agents directly onto the target area. There is a plethora of neuromodulation applications, which includes deep brain stimulation (DBS) treatment for Parkinson's disease, sacral nerve stimulation for pelvic disorders and incontinence, and spinal cord stimulation for ischemic disorders. Increasing prevalence of neurological disorders like Alzheimer’s and Parkinson’s diseases, and growing geriatric population are the major drivers for the market growth during the forecast period. The neuromodulation devices market is projected to demonstrate a sound growth by 2027, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period (2017 – 2027).The global neuromodulation devices market is growing with a sound pace. According to a recent study report published by

  A Biosimilar is described as a biological, medical product which is an identical copy of the original medical product. Market Research Future (MRFR) has published and released a research report Analyzing the market structure, this report estimates the future growth potential of the market. It observes the strategies of the key players in the market and follows the competitive developments like joint ventures, new product developments, mergers and acquisitions, research and developments (R & D) in the market. about the global biosimilars market that predicts massive enlargement for this market with 26% CAGR during the forecast period between 2016 and 2023. In terms of cash, the market has been anticipated to rise to the US $ 16.97 bn.This report also covers insights on the major countries/regions in which this industry is flourishing, along with the list and description of untapped regions which could be the potential markets in the future. The key factors aiding the growth o

  Technological advancements in medical devices and the availability of improved surgical processes, the market has expanded rigorously. Reduced complications from the use of spinal needles in spine related surgeries have increased their demand both from the doctors and patients end. Increase in the level of neurological disorders has further provided a push to this market in terms of investments in infrastructure and improvement of product quality. The Spinal Needle Market is estimated to develop at a CAGR of 6.8% during the forecasted period. Spinal needles market has developed considerably due to rise in demand for this particular equipment. Market Research Future, who publishes market reports related to the Healthcare sector among others, recently published a report on the scenario in this market. Major Key Players: The top players in this market segment are Halyard Health (US), Boston Scientific (US), MYCO Medical (US),   B. Braun (Germany), Medline Industries (US), Sarsted

  Antibody drug conjugate market is expected to grow by 19% by 2023. The antibody drug conjugate is a crucial biopharmaceutical therapy for cancer treatment. Antibody drug conjugates are the targeted therapy for the treatment of people suffering with cancer. It is the important class of highly potent biopharmaceutical drugs, with intend to target and kill only cancer cells. Antibody drug conjugates have quality of sensitive discrimination between healthy and diseased tissue. Antibody drug conjugates represent an innovative therapeutic application that combines the unique, high specificity, properties and anti-tumor activity of monoclonal antibodies (mAbs) that are tumor-specific but not sufficiently cytotoxic. According to National Instituted of Health (NIH) it has been found that in 2016, a projected 1,685,210 new cases of cancer will be detected in the United States and 595,690 individuals will die from the disease which further increases the growth of the market. Global Antibod

  Genes control heredity and offers the basic biological code to define the specific function of cell. Cells have unique process to defend themselves from attack from bacteria, viruses and fungi. The global gene editing market is expected to gain prominence over the forecast period growing rapidly. The market is forecasted to demonstrate a high growth by 2017. The global gene editing market Size is expected to grow at a CAGR of 18.30% during assessment period of 2017-2024. Global Gene editing Market - Competitive Analysis Characterized by the presence of several well-established and small players, the global market of gene editing appears to be highly competitive and fragmented. With well-established market in the North America region major companies like Thermo Fisher Scientific Inc, Sigma-Aldrich Corporation, New England Biolabs, Genscript Biotech Corporation, Integrated DNA Technologies, Inc and various others have their home in the region and generate maximum market share. The

  Market Research Future (MRFR) assessed the global Protein Engineering Market Report is expected to register a CAGR of 7.62% during the forecast period of 2021 to 2027. Protein engineering is creating and manufacturing non-natural polypeptides, often by modifying naturally occurring amino acid sequences. Synthetic proteins' structures and functions can now be generated entirely on a computer or created in the lab through directed evolution. The growth of the global protein engineering market is attributed to the increasing prevalence of chronic diseases and rising investments in synthetic biology. However, the lack of trained professionals in the market may hamper the market growth. Furthermore, the emerging markets of protein engineering pose viable opportunities for market expansion in the future. Protein Engineering Market Players MRFR recognizes the following companies as the key players in the global protein engineering market—Thermo Fisher Scientific (US), Bio-Rad Lab

  Global Menopause Treatment Market is expected to have a market value of USD 15,456.3 Million by 2027. For instance, in April 2019, Otsuka Pharmaceutical launched EQUELLE, a non-prescription, non-hormonal supplement to alleviate the frequency of hot flashes and muscle aches associated with menopause in the US. Such strategies push the demand for branded as well as generic menopausal drugs, thus promising huge growth for the industry. Menopause causes uncomfortable symptoms, such as hot flashes, vaginal dryness, and weight gain and menopause treatments such as hormonal and non-hormonal treatments help to relieve these symptoms. Over the years, major market players in the menopause treatment are focusing on various growth strategies such as product launches, product advancements and expansions to cater to the growing needs for patients seeking treatment for menopause symptoms. Key Players MRFR recognizes the following companies as the Key Players in the Global Menopause Treatment

  According to MRFR analysis, the global particle counter market is expected to register a CAGR of ~7.1% during the forecast period of 2019 to 2025 and was valued at USD 89.23 million in 2018.The growth of the global particle counter market is determined by numerous factors such as increasing incidence of chronic disorders, stringent regulatory scenario, and the adoption of particle counters to maintain air quality. However, the high cost of particle counters and technical limitations of particle counters is projected to restrain the growth of the market during the forecast period. A particle counter is a tool for monitoring indoor air quality to understand the concentration of particles in the air in cleanrooms and workplaces. This device would not identify specifically what kinds of dust particulates are present in the air, but it will identify how many airborne particles of a certain size are present in the environment. The global particle counter market is currently dominated

  Lymphatic obstruction or lymphedema is a long-term condition where the excess fluid forms in the body tissue and causes swelling commonly called edema. It develops due to the damaged lymphatic system. Sometimes it also develops after the treatment of breast cancer. According to MRFR analysis, the global lymphedema diagnostics market is expected to register a CAGR of ~7.1% during the forecast period of 2019 to 2025 and was valued at USD 22.6 million in 2018.The growth of the global lymphedema diagnostics market is determined by numerous factors such as increasing incidence of cancer, high prevalence of lymphedema, and the adoption of new diagnostic modalities. However, the short half-life of radiopharmaceuticals and the high cost of diagnostic tests is projected to restrain the growth of the market during the forecast period. The global lymphedema diagnostics market is currently dominated by several market players. The key players are involved in expansion, acquisition, and strat